Evidence map›Paper›PMID 32149004›Full record

ReviewKidney international supplements2020

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.

Roberto Pecoits-Filho, Ikechi G Okpechi, Jo-Ann Donner, David C H Harris, Harith M Aljubori, Aminu K Bello, Ezequiel Bellorin-Font, Fergus J Caskey, Allan Collins, Alfonso M Cueto-Manzano and 15 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Kidney international supplements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 8 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 8 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Home versus in-centre haemodialysis for people with kidney failure.The Cochrane database of systematic reviews · 2024
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dual trajectories of capacity management behavior and quality of life in hemodialysis patients: a longitudinal study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  17. Review
  18. Article
  19. 'Southern African journal of infectious diseases · 2026
    Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 16 countries.

Roberto Pecoits-FilhoSchool of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil.
Ikechi G OkpechiDivision of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
Jo-Ann DonnerInternational Society of Nephrology, Brussels, Belgium.
David C H HarrisCentre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Harith M AljuboriNephrology Department, Alqassimi Hospital, Sharjah, United Arab Emirates.
Aminu K BelloDivision of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Ezequiel Bellorin-FontDivision of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
Fergus J CaskeyUK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
Allan CollinsNxStage Medical, Inc., Lawrence, Massachusetts, USA.
Alfonso M Cueto-ManzanoUnidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.
John FeehallyUniversity of Leicester, Leicester, UK.
Bak Leong GohDepartment of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia.
Kitty J JagerEuropean Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
Masaomi NangakuDivision of Nephrology, The University of Tokyo School of Medicine, Hongo, Japan.
Muhibur RahmanDepartment of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh.
Manisha SahayDepartment of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India.
Abdulkarim SalehDepartment of Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Laura SolaDialysis Unit, Centro Asistencial del Sindicato Médico del Uruguay Institución de Asistencia Médica Privada de Profesionales Sin Fines de lucro, Montevideo, Uruguay.
Rumeyza Turan KazanciogluDivision of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
Rachael C WalkerDivision of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
Robert WalkerDepartment of Medicine, University of Otago, Dunedin, New Zealand.
Qiang YaoMedical Affairs, Baxter Healthcare, Guangzhou, China.
Xueqing YuDivision of Nephrology, Guangdong Provincial People's School of Medicine, South China University of Technology, Guangzhou, China.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
David W JohnsonCentre for Kidney Disease Research, University of Queensland, Brisbane, Australia.
Arbor Research Collaborative for Health · USBezmiâlem Vakıf Üniversitesi · TRGuangzhou Medical University · CNHawke's Bay Hospital · NZMexican Social Security Institute · MXMitford Hospital, DhakaNorth Bristol NHS Trust · GBOasis Hospital · AEOsmania General Hospital · INPeking University First Hospital · CNSaint Louis University · USSerdang Hospital · MYShaikh Khalifa Medical City · AESouth China University of Technology · CNThe University of Queensland · AUThe University of Tokyo · JPUniversity of Alberta · CAUniversity of Amsterdam · NLUniversity of Cape Town · ZAUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

Indexed as

end-stage kidney diseaseglobal healthhealth information systemshealth services accessibilitykidney replacement therapyregistries

Identifiers

PMID32149004
PMCPMC7031690
OpenAlexW3007800187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.